The most effective concentrated stock diversification combines several techniques: systematic gain harvesting in lower-income years, charitable giving of low-basis shares (donor-advised fund or qualified charity), exchange funds for very large positions, options-based hedging during transition periods, and 10b5-1 plans for executives subject to insider trading restrictions. The right combination depends on basis, position size, holding period, and time horizon.
Northern Suburbs households frequently accumulate concentrated stock through long careers at AbbVie, Abbott, Baxter, Walgreens, Zebra, or Northern Trust. A 30-year career often produces 7-figure positions in a single stock, sometimes representing 40-60% of total net worth. The risk is asymmetric: a single-company event (a failed clinical trial, an SEC investigation, a sector-wide regulatory change) can cut the position in half almost instantly.
Systematic gain harvesting is the simplest approach: sell a fixed dollar amount or percentage of the position annually, paying long-term capital gains tax (15% federal for most filers, plus 3.8% NIIT, plus 4.95% Illinois) on each sale. Concentrating sales in lower-income years (post-retirement, before Social Security claiming) reduces the rate. For a $2M low-basis position, even selling 10%/year over 7 years dramatically reduces concentration with manageable annual tax bills.
Charitable strategies are powerful for households planning meaningful charitable giving. Donating appreciated low-basis stock to a Donor-Advised Fund (DAF) or qualified charity provides a deduction at fair market value and eliminates capital gains tax on the donated shares. A household donating $50K/year can shift their giving from cash to appreciated stock and effectively diversify $50K/year of concentration tax-free. For larger one-time gifts (sale of business, large bonus year), a Charitable Remainder Trust (CRT) can sell the stock tax-free, generate income for the donor's lifetime, and benefit charity at death.
Exchange funds are a specialized solution for very large positions ($1M+). The investor contributes their concentrated stock to a partnership pool with other contributors holding different concentrated stocks; after a 7-year holding period, the investor receives back a diversified basket of all the contributors' stocks at the original basis. The result: diversification without immediate tax. Trade-offs include the 7-year lock-up, fees, and the requirement to be an accredited investor.
Key facts
- Federal capital gains tax: 15% (most filers) or 20% (highest bracket), plus 3.8% NIIT for high earners
- Illinois capital gains tax: 4.95% (no preferential rate)
- Total tax on appreciated stock: typically 18.8-28.8% depending on income level
- Donor-Advised Fund: deduction at FMV + capital gains eliminated for donated appreciated stock
- Exchange funds: 7-year lock-up; require accreditation; provide diversification without immediate tax
- Charitable Remainder Trust (CRT): sells stock tax-free inside trust; income to donor for life; remainder to charity
What is a 10b5-1 plan and do I need one?
A 10b5-1 plan is a pre-arranged trading plan that allows insiders (officers, directors, employees with material non-public information) to trade company stock without violating insider trading rules. The plan is established when no MNPI exists, specifies the timing and amount of future trades, and then executes automatically. For executives at AbbVie, Abbott, or Baxter selling concentrated stock, a 10b5-1 plan is essentially required to trade through earnings windows and other restricted periods. Plans typically have a cooling-off period (90+ days) before trades can begin and significant restrictions on amendments.
Should I use options to hedge a concentrated position?
Options-based hedging (collars, prepaid variable forwards, protective puts) can reduce single-stock risk during a transition period without triggering immediate sale. A typical collar: buy a put at 90% of current price to limit downside, sell a call at 110% to fund the put. This locks in a price range without selling the stock. Trade-offs: limits upside, may have a constructive sale issue if the collar is too tight (causing immediate tax), requires sophisticated execution, and complicates downstream sale planning. Best used as a bridge during a multi-year diversification plan, not as a permanent solution.
